HealthLynked appoints COO and adds two directors; targets Nasdaq uplist in 2026

HealthLynked Corp

Duncan McGillivray appointed COO effective Dec 8, 2025; base salary $120K/yr, rising to $150K on Nasdaq uplist.
McGillivray receives RSU grant of up to 180K shares: 90K vest ratably over 3 years, 90K upon Nasdaq uplist.
Jason Bishara and Chris G. Pulos appointed to Board effective Dec 1, 2025; each receives $20K annual compensation in shares.
Company plans to uplist to Nasdaq Capital Market in 2026, with McGillivray overseeing capital strategy and investor relations.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.